FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Stanley Davis

Research Profile

Objects

Microspheres

Concepts & Ideas

Chemicals & Drugs

Living Beings

Co-author Network

Publications

TOP 3
Stuart T Charlton; Joanne Whetstone; Susan T Fayinka; Kevin D Read; Lisbeth Illum; Stanley S Davis
Evaluation of direct transport pathways of glycine receptor antagonists and an angiotensin antagonist from the nasal cavity to the central nervous system in the rat model.
Stuart T Charlton; Stanley S Davis; Lisbeth Illum
Nasal administration of an angiotensin antagonist in the rat model: effect of bioadhesive formulations on the distribution of drugs to the systemic and central nervous systems.
Stuart T Charlton; Stanley S Davis; Lisbeth Illum
Evaluation of effect of ephedrine on the transport of drugs from the nasal cavity to the systemic circulation and the central nervous system.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Stanley Davis (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Stuart T Charlton; Joanne Whetstone; Susan T Fayinka; Kevin D Read; Lisbeth Illum; Stanley S Davis
Evaluation of direct transport pathways of glycine receptor antagonists and an angiotensin antagonist from the nasal cavity to the central nervous system in the rat model.
Pharmaceutical research 2008;25(7):1531-43.
2007: Stuart T Charlton; Stanley S Davis; Lisbeth Illum
Nasal administration of an angiotensin antagonist in the rat model: effect of bioadhesive formulations on the distribution of drugs to the systemic and central nervous systems.
International journal of pharmaceutics 2007;338(1-2):94-103.
2007: Stuart T Charlton; Stanley S Davis; Lisbeth Illum
Evaluation of effect of ephedrine on the transport of drugs from the nasal cavity to the systemic circulation and the central nervous system.
Journal of drug targeting 2007;15(5):370-7.
2007: Stuart T Charlton; Stanley S Davis; Lisbeth Illum
Evaluation of bioadhesive polymers as delivery systems for nose to brain delivery: in vitro characterisation studies.
Journal of controlled release : official journal of the Controlled Release Society 2007;118(2):225-34.
2007: Stuart T Charlton; Nick S Jones; Stanley S Davis; Lisbeth Illum
Distribution and clearance of bioadhesive formulations from the olfactory region in man: effect of polymer type and nasal delivery device.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2007;30(3-4):295-302.
2006: Stanley S Davis
The use of soluble polymers and polymer microparticles to provide improved vaccine responses after parenteral and mucosal delivery.
Vaccine 2006;24 Suppl 2():S2-7-10.
2005: Snjezana Stolnik; CR Heald; M G Garnett; Lisbeth Illum; Stanley S Davis
Differences in the adsorption behaviour of poly(ethylene oxide) copolymers onto model polystyrene nanoparticles assessed by isothermal titration microcalorimetry correspond to the biological differences.
Journal of drug targeting 2005;13(8-9):449-58.
2005: Stanley S Davis
Formulation strategies for absorption windows.
Drug discovery today 2005;10(4):249-57.
2004: Mark A Robinson; Stuart T Charlton; Philippe Garnier; Xiang-tao Wang; Stanley S Davis; Alan C Perkins; Malcolm Frier; Ruth Duncan; Tony J Savage; David A Wyatt; Susan A Watson; Benjamin G Davis
LEAPT: lectin-directed enzyme-activated prodrug therapy.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(40):14527-32.
2004: Jihong Han; Stanley S Davis; Catherine Papandreou; Colin D Melia; Clive Washington
Design and evaluation of an emulsion vehicle for paclitaxel. I. Physicochemical properties and plasma stability.
Pharmaceutical research 2004;21(9):1573-80.
2004: Stanley S Davis
Coming of age of lipid-based drug delivery systems.
Advanced drug delivery reviews 2004;56(9):1241-2.
2003: Lisbeth Illum; Michael Hinchcliffe; Stanley S Davis
The effect of blood sampling site and physicochemical characteristics of drugs on bioavailability after nasal administration in the sheep model.
Pharmaceutical research 2003;20(9):1474-84.
2003: M Iqbal; Wu Lin; Inderjit Jabbal-Gill; Stanley S Davis; Michael W Steward; Lisbeth Illum
Nasal delivery of chitosan-DNA plasmid expressing epitopes of respiratory syncytial virus (RSV) induces protective CTL responses in BALB/c mice.
Vaccine 2003;21(13-14):1478-85.
2003: Stanley S Davis; Lisbeth Illum
Absorption enhancers for nasal drug delivery.
Clinical pharmacokinetics 2003;42(13):1107-28.
2002: Stanley S Davis
Parenteral polymers.
Drug discovery today 2002;7(23):1159-61.
2002: Clair L Dobson; Stanley S Davis; Sushil Chauhan; Robert A Sparrow; Ian R Wilding
The effect of ileal brake activators on the oral bioavailability of atenolol in man.
International journal of pharmaceutics 2002;248(1-2):61-70.
2002: Benjamin J Rackstraw; Snjezana Stolnik; Stanley S Davis; Fabio Bignotti; Martin C Garnett
Development of multicomponent DNA delivery systems based upon poly(amidoamine)-PEG co-polymers.
Biochimica et biophysica acta 2002;1576(3):269-86.
2002: Lisbeth Illum; Peter Watts; AN Fisher; Michael Hinchcliffe; H Norbury; Inderjit Jabbal-Gill; Richard Nankervis; Stanley S Davis
Intranasal delivery of morphine.
The Journal of pharmacology and experimental therapeutics 2002;301(1):391-400.
2002: Yu Hui Cheng; Peter Watts; Michael Hinchcliffe; R Hotchkiss; Richard Nankervis; N F Faraj; Alan Smith; Stanley S Davis; Lisbeth Illum
Development of a novel nasal nicotine formulation comprising an optimal pulsatile and sustained plasma nicotine profile for smoking cessation.
Journal of controlled release : official journal of the Controlled Release Society 2002;79(1-3):243-54.
2001: Snjezana Stolnik; B Daudali; A Arien; Joanne Whetstone; CR Heald; Martin C Garnett; Stanley S Davis; Lisbeth Illum
The effect of surface coverage and conformation of poly(ethylene oxide) (PEO) chains of poloxamer 407 on the biological fate of model colloidal drug carriers.
Biochimica et biophysica acta 2001;1514(2):261-79.
2001: Inderjit Jabbal-Gill; Wu Lin; O Kistner; Stanley S Davis; Lisbeth Illum
Polymeric lamellar substrate particles for intranasal vaccination.
Advanced drug delivery reviews 2001;51(1-3):97-111.
2001: Lisbeth Illum; Inderjit Jabbal-Gill; Michael Hinchcliffe; AN Fisher; Stanley S Davis
Chitosan as a novel nasal delivery system for vaccines.
Advanced drug delivery reviews 2001;51(1-3):81-96.
2001: Stanley S Davis
Nasal vaccines.
Advanced drug delivery reviews 2001;51(1-3):21-42.
2001: Thirumala Govender; Snjezana Stolnik; C Xiong; S Zhang; Lisbeth Illum; Stanley S Davis
Drug-polyionic block copolymer interactions for micelle formation: physicochemical characterisation.
Journal of controlled release : official journal of the Controlled Release Society 2001;75(3):249-58.
2001: Lisbeth Illum; AN Fisher; Inderjit Jabbal-Gill; Stanley S Davis
Bioadhesive starch microspheres and absorption enhancing agents act synergistically to enhance the nasal absorption of polypeptides.
International journal of pharmaceutics 2001;222(1):109-19.
2001: Lisbeth Illum; A E Church; M D Butterworth; A Arien; Joanne Whetstone; Stanley S Davis
Development of systems for targeting the regional lymph nodes for diagnostic imaging: in vivo behaviour of colloidal PEG-coated magnetite nanospheres in the rat following interstitial administration.
Pharmaceutical research 2001;18(5):640-5.
2001: RJ Soane; Michael Hinchcliffe; Stanley S Davis; Lisbeth Illum
Clearance characteristics of chitosan based formulations in the sheep nasal cavity.
International journal of pharmaceutics 2001;217(1-2):183-91.
2001: IR Hill; Martin C Garnett; Fabio Bignotti; Stanley S Davis
Determination of protection from serum nuclease activity by DNA-polyelectrolyte complexes using an electrophoretic method.
Analytical biochemistry 2001;291(1):62-8.
2001: J Han; Stanley S Davis; C Washington
Physical properties and stability of two emulsion formulations of propofol.
International journal of pharmaceutics 2001;215(1-2):207-20.
2001: W Lin; Martin C Garnett; Stanley S Davis; Etienne Schacht; Paolo Ferruti; Lisbeth Illum
Preparation and characterisation of rose Bengal-loaded surface-modified albumin nanoparticles.
Journal of controlled release : official journal of the Controlled Release Society 2001;71(1):117-26.
2001: H M Redhead; Stanley S Davis; Lisbeth Illum
Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluation.
Journal of controlled release : official journal of the Controlled Release Society 2001;70(3):353-63.
2001: RJ Soane; A S Carney; Nick S Jones; Malcolm Frier; Alan C Perkins; Stanley S Davis; Lisbeth Illum
The effect of the nasal cycle on mucociliary clearance.
Clinical otolaryngology and allied sciences 2001;26(1):9-15.
2001: Snjezana Stolnik; CR Heald; J Neal; Martin C Garnett; Stanley S Davis; Lisbeth Illum; S C Purkis; R J Barlow; P R Gellert
Polylactide-poly(ethylene glycol) micellar-like particles as potential drug carriers: production, colloidal properties and biological performance.
Journal of drug targeting 2001;9(5):361-78.
2001: J Brooking; Stanley S Davis; Lisbeth Illum
Transport of nanoparticles across the rat nasal mucosa.
Journal of drug targeting 2001;9(4):267-79.
2001: Stanley S Davis; Lisbeth Illum; Michael Hinchcliffe
Gastrointestinal transit of dosage forms in the pig.
The Journal of pharmacy and pharmacology 2001;53(1):33-9.
2000: N A Jones; IR Hill; Snjezana Stolnik; Fabio Bignotti; Stanley S Davis; Martin C Garnett
Polymer chemical structure is a key determinant of physicochemical and colloidal properties of polymer-DNA complexes for gene delivery.
Biochimica et biophysica acta 2000;1517(1):1-18.
2000: Edel A McNeela; D O'Connor; Inderjit Jabbal-Gill; Lisbeth Illum; Stanley S Davis; Mariagrazia Pizza; Samuele Peppoloni; Rino Rappuoli; Kingston H G Mills
A mucosal vaccine against diphtheria: formulation of cross reacting material (CRM(197)) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal delivery.
Vaccine 2000;19(9-10):1188-98.
2000: Thirumala Govender; T Riley; Touraj Ehtezazi; Martin C Garnett; Snjezana Stolnik; Lisbeth Illum; Stanley S Davis
Defining the drug incorporation properties of PLA-PEG nanoparticles.
International journal of pharmaceutics 2000;199(1):95-110.
2000: Clair L Dobson; Stanley S Davis; Sushil Chauhan; Robert A Sparrow; Ian R Wilding
Does the site of intestinal delivery of oleic acid alter the ileal brake response?
International journal of pharmaceutics 2000;195(1-2):63-70.
2000: Y H Cheng; Lisbeth Illum; Stanley S Davis
Schizophrenia and drug delivery systems.
Journal of drug targeting 2000;8(2):107-17.
1999: W Lin; Martin C Garnett; Etienne Schacht; Stanley S Davis; Lisbeth Illum
Preparation and in vitro characterization of HSA-mPEG nanoparticles.
International journal of pharmaceutics 1999;189(2):161-70.
1999: P He; Stanley S Davis; Lisbeth Illum
Chitosan microspheres prepared by spray drying.
International journal of pharmaceutics 1999;187(1):53-65.
1999: Inderjit Jabbal-Gill; Wu Lin; P Jenkins; Peter Watts; M Jimenez; Lisbeth Illum; Stanley S Davis; J M Wood; D Major; Philip D Minor; X Li; E C Lavelle; A G A Coombes
Potential of polymeric lamellar substrate particles (PLSP) as adjuvants for vaccines.
Vaccine 1999;18(3-4):238-50.
1999: A Delgado; E C Lavelle; M Hartshorne; Stanley S Davis
PLG microparticles stabilised using enteric coating polymers as oral vaccine delivery systems.
Vaccine 1999;17(22):2927-38.
1999: Thirumala Govender; Touraj Ehtezazi; Snjezana Stolnik; Lisbeth Illum; Stanley S Davis
Complex formation between the anionic polymer (PAA) and a cationic drug (procaine HCI): characterization by microcalorimetric studies.
Pharmaceutical research 1999;16(7):1125-31.
1999: P D Scholes; A G A Coombes; Lisbeth Illum; Stanley S Davis; JF Watts; C Ustariz; M Vert; Martyn C Davies
Detection and determination of surface levels of poloxamer and PVA surfactant on biodegradable nanospheres using SSIMS and XPS.
Journal of controlled release : official journal of the Controlled Release Society 1999;59(3):261-78.
1999: A G A Coombes; E C Lavelle; Stanley S Davis
Biodegradable lamellar particles of poly(lactide) induce sustained immune responses to a single dose of adsorbed protein.
Vaccine 1999;17(19):2410-22.
1999: P He; Stanley S Davis; Lisbeth Illum
Sustained release chitosan microspheres prepared by novel spray drying methods.
Journal of microencapsulation 1999;16(3):343-55.
1999: IR Hill; Martin C Garnett; Fabio Bignotti; Stanley S Davis
In vitro cytotoxicity of poly(amidoamine)s: relevance to DNA delivery.
Biochimica et biophysica acta 1999;1427(2):161-74.
1999: Rita Cortesi; E Esposito; M Osti; G Squarzoni; Enea Menegatti; Stanley S Davis; Claudio Nastruzzi
Dextran cross-linked gelatin microspheres as a drug delivery system.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 1999;47(2):153-60.
1999: E C Lavelle; Ming-Kung Yeh; A G A Coombes; Stanley S Davis
The stability and immunogenicity of a protein antigen encapsulated in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol.
Vaccine 1999;17(6):512-29.
1999: RJ Soane; Malcolm Frier; Alan C Perkins; Nick S Jones; Stanley S Davis; Lisbeth Illum
Evaluation of the clearance characteristics of bioadhesive systems in humans.
International journal of pharmaceutics 1999;178(1):55-65.
1999: Thirumala Govender; Snjezana Stolnik; Martin C Garnett; Lisbeth Illum; Stanley S Davis
PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug.
Journal of controlled release : official journal of the Controlled Release Society 1999;57(2):171-85.
1999: Clair L Dobson; Stanley S Davis; Sushil Chauhan; Robert A Sparrow; Ian R Wilding
The effect of oleic acid on the human ileal brake and its implications for small intestinal transit of tablet formulations.
Pharmaceutical research 1999;16(1):92-6.
1998: Inderjit Jabbal-Gill; AN Fisher; Rino Rappuoli; Stanley S Davis; Lisbeth Illum
Stimulation of mucosal and systemic antibody responses against Bordetella pertussis filamentous haemagglutinin and recombinant pertussis toxin after nasal administration with chitosan in mice.
Vaccine 1998;16(20):2039-46.
1998: Y H Cheng; Lisbeth Illum; Stanley S Davis
A poly(D,L-lactide-co-glycolide) microsphere depot system for delivery of haloperidol.
Journal of controlled release : official journal of the Controlled Release Society 1998;55(2-3):203-12.
1998: J C Neal; Snjezana Stolnik; Etienne Schacht; E R Kenawy; Martin C Garnett; Stanley S Davis; Lisbeth Illum
In vitro displacement by rat serum of adsorbed radiolabeled poloxamer and poloxamine copolymers from model and biodegradable nanospheres.
Journal of pharmaceutical sciences 1998;87(10):1242-8.
1998: Rita Cortesi; Claudio Nastruzzi; Stanley S Davis
Sugar cross-linked gelatin for controlled release: microspheres and disks.
Biomaterials 1998;19(18):1641-9.
1998: A G A Coombes; D Major; J M Wood; David J Hockley; Philip D Minor; Stanley S Davis
Resorbable lamellar particles of polylactide as adjuvants for influenza virus vaccines.
Biomaterials 1998;19(11-12):1073-81.
1998: Clair L Dobson; Michael Hinchcliffe; Stanley S Davis; Sushil Chauhan; Ian R Wilding
Is the pig a good animal model for studying the human ileal brake?
Journal of pharmaceutical sciences 1998;87(5):565-8.
1998: AE Hawley; Lisbeth Illum; Stanley S Davis
The effect of lymphatic oedema on the uptake of colloids to the lymph nodes.
Biopharmaceutics & drug disposition 1998;19(3):193-7.
1998: A G A Coombes; Ming-Kung Yeh; E C Lavelle; Stanley S Davis
The control of protein release from poly(DL-lactide co-glycolide) microparticles by variation of the external aqueous phase surfactant in the water-in oil-in water method.
Journal of controlled release : official journal of the Controlled Release Society 1998;52(3):311-20.
1998: J C Neal; Snjezana Stolnik; Martin C Garnett; Stanley S Davis; Lisbeth Illum
Modification of the copolymers poloxamer 407 and poloxamine 908 can affect the physical and biological properties of surface modified nanospheres.
Pharmaceutical research 1998;15(2):318-24.
1998: H Takahata; E C Lavelle; A G A Coombes; Stanley S Davis
The distribution of protein associated with poly(DL-lactide co-glycolide) microparticles and its degradation in simulated body fluids.
Journal of controlled release : official journal of the Controlled Release Society 1998;50(1-3):237-46.
1998: I J Gill; AN Fisher; N Farraj; C G Pitt; Stanley S Davis; Lisbeth Illum
Intranasal absorption of granulocyte-colony stimulating factor (G-CSF) from powder formulations, in sheep.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 1998;6(1):1-10.
1997: H Rafati; E C Lavelle; A G A Coombes; Snjezana Stolnik; J Holland; Stanley S Davis
The immune response to a model antigen associated with PLG microparticles prepared using different surfactants.
Vaccine 1997;15(17-18):1888-97.
1997: TI Armstrong; SM Moghimi; Stanley S Davis; Lisbeth Illum
Activation of the mononuclear phagocyte system by poloxamine 908: its implications for targeted drug delivery.
Pharmaceutical research 1997;14(11):1629-33.
1997: A G A Coombes; S Tasker; M Lindblad; J Holmgren; K Hoste; Veska Toncheva; Etienne Schacht; Martyn C Davies; Lisbeth Illum; Stanley S Davis
Biodegradable polymeric microparticles for drug delivery and vaccine formulation: the surface attachment of hydrophilic species using the concept of poly(ethylene glycol) anchoring segments.
Biomaterials 1997;18(17):1153-61.
1997: J Vandorpe; E Schacht; S Dunn; AE Hawley; Snjezana Stolnik; Stanley S Davis; Martin C Garnett; M C Davies; Lisbeth Illum
Long circulating biodegradable poly(phosphazene) nanoparticles surface modified with poly(phosphazene)-poly(ethylene oxide) copolymer.
Biomaterials 1997;18(17):1147-52.
1997: J Brown; G Hooper; CJ Kenyon; Stuart T. Haines; J Burt; J M Humphries; Stephen P Newman; Stanley S Davis; Robert A Sparrow; Ian R Wilding
Spreading and retention of vaginal formulations in post-menopausal women as assessed by gamma scintigraphy.
Pharmaceutical research 1997;14(8):1073-8.
1997: AE Hawley; Lisbeth Illum; Stanley S Davis
Preparation of biodegradable, surface engineered PLGA nanospheres with enhanced lymphatic drainage and lymph node uptake.
Pharmaceutical research 1997;14(5):657-61.
1997: W Lin; Martin C Garnett; Martyn C Davies; Fabio Bignotti; Paolo Ferruti; Stanley S Davis; Lisbeth Illum
Preparation of surface-modified albumin nanospheres.
Biomaterials 1997;18(7):559-65.
1997: AE Hawley; Lisbeth Illum; Stanley S Davis
Lymph node localisation of biodegradable nanospheres surface modified with poloxamer and poloxamine block co-polymers.
FEBS letters 1997;400(3):319-23.
1996: N W Thomas; P G Jenkins; K A Howard; M W Smith; E C Lavelle; J Holland; Stanley S Davis
Particle uptake and translocation across epithelial membranes.
Journal of anatomy 1996;189 ( Pt 3)():487-90.
1996: Ming-Kung Yeh; Stanley S Davis; A G A Coombes
Improving protein delivery from microparticles using blends of poly(DL lactide co-glycolide) and poly(ethylene oxide)-poly(propylene oxide) copolymers.
Pharmaceutical research 1996;13(11):1693-8.
1996: Lisbeth Illum; Stanley S Davis; M Pawula; AN Fisher; David A Barrett; N F Farraj; P Nicholas Shaw
Nasal administration of morphine-6-glucuronide in sheep--a pharmacokinetic study.
Biopharmaceutics & drug disposition 1996;17(8):717-24.
1996: A Avdeef; David A Barrett; P Nicholas Shaw; R D Knaggs; Stanley S Davis
Octanol-, chloroform-, and propylene glycol dipelargonat-water partitioning of morphine-6-glucuronide and other related opiates.
Journal of medicinal chemistry 1996;39(22):4377-81.
1996: A G A Coombes; E C Lavelle; P G Jenkins; Stanley S Davis
Single dose, polymeric, microparticle-based vaccines: the influence of formulation conditions on the magnitude and duration of the immune response to a protein antigen.
Vaccine 1996;14(15):1429-38.
1996: M R Lance; C Washington; Stanley S Davis
Evidence for the formation of amphotericin B-phospholipid complexes in Langmuir monolayers.
Pharmaceutical research 1996;13(7):1008-14.
1995: D A Adkin; Stanley S Davis; Robert A Sparrow; P D Huckle; Ian R Wilding
The effect of mannitol on the oral bioavailability of cimetidine.
Journal of pharmaceutical sciences 1995;84(12):1405-9.
1995: Martin Vordermeier; A G A Coombes; P Jenkins; JP McGee; D T O'Hagan; Stanley S Davis; M Singh
Synthetic delivery system for tuberculosis vaccines: immunological evaluation of the M. tuberculosis 38 kDa protein entrapped in biodegradable PLG microparticles.
Vaccine 1995;13(16):1576-82.
1995: M R Lance; C Washington; Stanley S Davis
Structure and toxicity of amphotericin B/triglyceride emulsion formulations.
The Journal of antimicrobial chemotherapy 1995;36(1):119-28.
1995: G R Harper; Stanley S Davis; Martyn C Davies; M E Norman; T F Tadros; D C Taylor; M P Irving; J A Waters; J F Watts
Influence of surface coverage with poly(ethylene oxide) on attachment of sterically stabilized microspheres to rat Kupffer cells in vitro.
Biomaterials 1995;16(6):427-39.
1995: D A Adkin; Stanley S Davis; Robert A Sparrow; P D Huckle; A J Phillips; Ian R Wilding
The effects of pharmaceutical excipients on small intestinal transit.
British journal of clinical pharmacology 1995;39(4):381-7.
1995: D A Adkin; Stanley S Davis; Robert A Sparrow; P D Huckle; A J Phillips; Ian R Wilding
The effect of different concentrations of mannitol in solution on small intestinal transit: implications for drug absorption.
Pharmaceutical research 1995;12(3):393-6.
1995: P G Jenkins; A G A Coombes; Ming-Kung Yeh; N W Thomas; Stanley S Davis
Aspects of the design and delivery of microparticles for vaccine applications.
Journal of drug targeting 1995;3(1):79-81.
1994: Snjezana Stolnik; S E Dunn; Martin C Garnett; Martyn C Davies; A G A Coombes; D C Taylor; M P Irving; S C Purkiss; T F Tadros; Stanley S Davis
Surface modification of poly(lactide-co-glycolide) nanospheres by biodegradable poly(lactide)-poly(ethylene glycol) copolymers.
Pharmaceutical research 1994;11(12):1800-8.
1994: W Lin; A G A Coombes; Martin C Garnett; Martyn C Davies; Etienne Schacht; Stanley S Davis; Lisbeth Illum
Preparation of sterically stabilized human serum albumin nanospheres using a novel Dextranox-MPEG crosslinking agent.
Pharmaceutical research 1994;11(11):1588-92.
1994: M B Awang; J G Hardy; Stanley S Davis; M V Pimm; S J Parry; Ian R Wilding
Evaluation of 153Sm-diethylenetriaminepentaacetic acid for radiolabelling of pharmaceutical dosage forms by neutron activation.
Nuclear medicine and biology 1994;21(7):905-9.
1994: Lisbeth Illum; N F Farraj; Stanley S Davis
Chitosan as a novel nasal delivery system for peptide drugs.
Pharmaceutical research 1994;11(8):1186-9.
1994: H Critchley; Stanley S Davis; N F Farraj; Lisbeth Illum
Nasal absorption of desmopressin in rats and sheep. Effect of a bioadhesive microsphere delivery system.
The Journal of pharmacy and pharmacology 1994;46(8):651-6.
1994: A G A Coombes; P D Scholes; Martyn C Davies; Lisbeth Illum; Stanley S Davis
Resorbable polymeric microspheres for drug delivery--production and simultaneous surface modification using PEO-PPO surfactants.
Biomaterials 1994;15(9):673-80.
1994: S E Dunn; A Brindley; Stanley S Davis; Martyn C Davies; Lisbeth Illum
Polystyrene-poly (ethylene glycol) (PS-PEG2000) particles as model systems for site specific drug delivery. 2. The effect of PEG surface density on the in vitro cell interaction and in vivo biodistribution.
Pharmaceutical research 1994;11(7):1016-22.
1994: C Q Chen; W Lin; A G A Coombes; Stanley S Davis; Lisbeth Illum
Preparation of human serum albumin microspheres by a novel acetone-heat denaturation method.
Journal of microencapsulation 1994;11(4):395-407.
1994: Ian R Wilding; Stanley S Davis; D T O'Hagan
Optimizing gastrointestinal delivery of drugs.
Baillière's clinical gastroenterology 1994;8(2):255-70.
1994: SM Moghimi; AE Hawley; N M Christy; T Gray; Lisbeth Illum; Stanley S Davis
Surface engineered nanospheres with enhanced drainage into lymphatics and uptake by macrophages of the regional lymph nodes.
FEBS letters 1994;344(1):25-30.
1994: Ian R Wilding; Stanley S Davis; D T O'Hagan
Targeting of drugs and vaccines to the gut.
Pharmacology & therapeutics 1994;62(1-2):97-124.
1994: SM Moghimi; Stanley S Davis
Innovations in avoiding particle clearance from blood by Kupffer cells: cause for reflection.
Critical reviews in therapeutic drug carrier systems 1994;11(1):31-59.
1993: SM Moghimi; H Hedeman; N M Christy; Lisbeth Illum; Stanley S Davis
Enhanced hepatic clearance of intravenously administered sterically stabilized microspheres in zymosan-stimulated rats.
Journal of leukocyte biology 1993;54(6):513-7.
1993: SM Moghimi; I S Muir; Lisbeth Illum; Stanley S Davis; V Kolb-Bachofen
Coating particles with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum.
Biochimica et biophysica acta 1993;1179(2):157-65.
1993: David A Barrett; J Simpson; N Rutter; T Kurihara-Bergstrom; P Nicholas Shaw; Stanley S Davis
The pharmacokinetics and physiological effects of buprenorphine infusion in premature neonates.
British journal of clinical pharmacology 1993;36(3):215-9.
1993: SM Moghimi; H Hedeman; I S Muir; Lisbeth Illum; Stanley S Davis
An investigation of the filtration capacity and the fate of large filtered sterically-stabilized microspheres in rat spleen.
Biochimica et biophysica acta 1993;1157(3):233-40.
1993: B K Sidhu; C Washington; Stanley S Davis; T S Purewal
Rheology of model aerosol suspensions.
The Journal of pharmacy and pharmacology 1993;45(7):597-600.
1993: J M Price; Stanley S Davis; Ian R Wilding
Characterization of colonic transit of nondisintegrating tablets in healthy subjects.
Digestive diseases and sciences 1993;38(6):1015-21.
1993: SM Moghimi; H Hedeman; Lisbeth Illum; Stanley S Davis
Effect of splenic congestion associated with haemolytic anaemia on filtration of 'spleen-homing' microspheres.
Clinical science (London, England : 1979) 1993;84(6):605-9.
1993: C Washington; M Lance; Stanley S Davis
Toxicity of amphotericin B emulsion formulations.
The Journal of antimicrobial chemotherapy 1993;31(5):806-8.
1993: J M Price; Stanley S Davis; Robert A Sparrow; Ian R Wilding
The effect of meal composition on the gastrocolonic response: implications for drug delivery to the colon.
Pharmaceutical research 1993;10(5):722-6.
1993: David A Barrett; N Rutter; Stanley S Davis
An in vitro study of diamorphine permeation through premature human neonatal skin.
Pharmaceutical research 1993;10(4):583-7.
1993: C Washington; F Koosha; Stanley S Davis
Physicochemical properties of parenteral fat emulsions containing 20% triglyceride; Intralipid and Ivelip.
Journal of clinical pharmacy and therapeutics 1993;18(2):123-31.
1993: H Jeffery; Stanley S Davis; D T O'Hagan
The preparation and characterization of poly(lactide-co-glycolide) microparticles. II. The entrapment of a model protein using a (water-in-oil)-in-water emulsion solvent evaporation technique.
Pharmaceutical research 1993;10(3):362-8.
1993: D T O'Hagan; H Jeffery; Stanley S Davis
Long-term antibody responses in mice following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticles.
Vaccine 1993;11(9):965-9.
1993: W Lin; A G A Coombes; Martyn C Davies; Stanley S Davis; Lisbeth Illum
Preparation of sub-100 nm human serum albumin nanospheres using a pH-coacervation method.
Journal of drug targeting 1993;1(3):237-43.
1992: Ian R Wilding; J G Hardy; Robert A Sparrow; Stanley S Davis; P B Daly; J R English
In vivo evaluation of enteric-coated naproxen tablets using gamma scintigraphy.
Pharmaceutical research 1992;9(11):1436-41.
1992: AN Fisher; Lisbeth Illum; Stanley S Davis; E H Schacht
Di-iodo-L-tyrosine-labelled dextrans as molecular size markers of nasal absorption in the rat.
The Journal of pharmacy and pharmacology 1992;44(7):550-4.
1992: B T Henry; J Adler; S Hibberd; M S Cheema; Stanley S Davis; T G Rogers
Epi-fluorescence microscopy and image analysis used to measure diffusion coefficients in gel systems.
The Journal of pharmacy and pharmacology 1992;44(7):543-9.
1992: C J Porter; SM Moghimi; Lisbeth Illum; Stanley S Davis
The polyoxyethylene/polyoxypropylene block co-polymer poloxamer-407 selectively redirects intravenously injected microspheres to sinusoidal endothelial cells of rabbit bone marrow.
FEBS letters 1992;305(1):62-6.
1992: Stephen Challacombe; D Rahman; H Jeffery; Stanley S Davis; D T O'Hagan
Enhanced secretory IgA and systemic IgG antibody responses after oral immunization with biodegradable microparticles containing antigen.
Immunology 1992;76(1):164-8.
1992: Ian R Wilding; Stanley S Davis; M Bakhshaee; H N Stevens; Robert A Sparrow; J Brennan
Gastrointestinal transit and systemic absorption of captopril from a pulsed-release formulation.
Pharmaceutical research 1992;9(5):654-7.
1992: Stanley S Davis
Delivery systems for biopharmaceuticals.
The Journal of pharmacy and pharmacology 1992;44 Suppl 1():186-90.
1992: Stanley S Davis; J G Hardy; Stephen P Newman; Ian R Wilding
Gamma scintigraphy in the evaluation of pharmaceutical dosage forms.
European journal of nuclear medicine 1992;19(11):971-86.
1991: Ian R Wilding; Stanley S Davis; J G Hardy; C S Robertson; V A John; M L Powell; M Leal; P Lloyd; S M Walker
Relationship between systemic drug absorption and gastrointestinal transit after the simultaneous oral administration of carbamazepine as a controlled-release system and as a suspension of 15N-labelled drug to healthy volunteers.
British journal of clinical pharmacology 1991;32(5):573-9.
1991: A J Coupe; Stanley S Davis; D F Evans; Ian R Wilding
Correlation of the gastric emptying of nondisintegrating tablets with gastrointestinal motility.
Pharmaceutical research 1991;8(10):1281-5.
1991: D T O'Hagan; H Jeffery; M J Roberts; JP McGee; Stanley S Davis
Controlled release microparticles for vaccine development.
Vaccine 1991;9(10):768-71.
1991: A C Elias-Jones; David A Barrett; N Rutter; P Nicholas Shaw; Stanley S Davis
Diamorphine infusion in the preterm neonate.
Archives of disease in childhood 1991;66(10 Spec No):1155-7.
1991: G R Harper; Martyn C Davies; Stanley S Davis; T F Tadros; D C Taylor; M P Irving; J A Waters
Steric stabilization of microspheres with grafted polyethylene oxide reduces phagocytosis by rat Kupffer cells in vitro.
Biomaterials 1991;12(7):695-700.
1991: Ian R Wilding; J G Hardy; Stanley S Davis; Colin D Melia; D F Evans; A H Short; Robert A Sparrow; K C Yeh
Characterisation of the in vivo behaviour of a controlled-release formulation of levodopa (Sinemet CR).
Clinical neuropharmacology 1991;14(4):305-21.
1991: I S Muir; SM Moghimi; Lisbeth Illum; Stanley S Davis; Martyn C Davies
The effect of block co-polymers on the uptake of model polystyrene microspheres by Kupffer cells--in vitro and in vivo studies.
Biochemical Society transactions 1991;19(3):329S.
1991: David A Barrett; A C Elias-Jones; N Rutter; P Nicholas Shaw; Stanley S Davis
Morphine kinetics after diamorphine infusion in premature neonates.
British journal of clinical pharmacology 1991;32(1):31-7.
1991: K A Lamb; C Washington; Stanley S Davis; S P Denyer
Toxicity of amphotericin B emulsion to cultured canine kidney cell monolayers.
The Journal of pharmacy and pharmacology 1991;43(7):522-4.
1991: SM Moghimi; C J Porter; I S Muir; Lisbeth Illum; Stanley S Davis
Non-phagocytic uptake of intravenously injected microspheres in rat spleen: influence of particle size and hydrophilic coating.
Biochemical and biophysical research communications 1991;177(2):861-6.
1991: D T O'Hagan; D Rahman; JP McGee; H Jeffery; M C Davies; P Williams; Stanley S Davis; Stephen Challacombe
Biodegradable microparticles as controlled release antigen delivery systems.
Immunology 1991;73(2):239-42.
1991: David A Barrett; P Nicholas Shaw; Stanley S Davis
Determination of morphine and 6-acetylmorphine in plasma by high-performance liquid chromatography with fluorescence detection.
Journal of chromatography 1991;566(1):135-45.
1991: A J Coupe; Stanley S Davis; Ian R Wilding
Variation in gastrointestinal transit of pharmaceutical dosage forms in healthy subjects.
Pharmaceutical research 1991;8(3):360-4.
1991: Stanley S Davis
Physiological factors in drug absorption.
Annals of the New York Academy of Sciences 1991;618():140-9.
1990: D T O'Hagan; H Critchley; N F Farraj; AN Fisher; B R Johansen; Stanley S Davis; Lisbeth Illum
Nasal absorption enhancers for biosynthetic human growth hormone in rats.
Pharmaceutical research 1990;7(7):772-6.
1990: R G Cartwright; P H Cartlidge; N Rutter; Colin D Melia; Stanley S Davis
Transdermal delivery of theophylline to premature infants using a hydrogel disc system.
British journal of clinical pharmacology 1990;29(5):533-9.
1990: SM Moghimi; Lisbeth Illum; Stanley S Davis
Physiopathological and physicochemical considerations in targeting of colloids and drug carriers to the bone marrow.
Critical reviews in therapeutic drug carrier systems 1990;7(3):187-209.
1989: Colin D Melia; Stanley S Davis
Review article: mechanisms of drug release from tablets and capsules. 2. Dissolution.
Alimentary pharmacology & therapeutics 1989;3(6):513-25.
1989: M T Anderson; S E Harding; Stanley S Davis
On the interaction in solution of a candidate mucoadhesive polymer, diethylaminoethyl-dextran, with pig gastric mucus glycoprotein.
Biochemical Society transactions 1989;17(6):1101-2.
1989: Ian R Wilding; Stanley S Davis; Colin D Melia; J G Hardy; D F Evans; A H Short; Robert A Sparrow
Gastrointestinal transit of Sinemet CR in healthy volunteers.
Neurology 1989;39(11 Suppl 2):53-8.
1989: D T O'Hagan; K Palin; Stanley S Davis; P Artursson; I Sjöholm
Microparticles as potentially orally active immunological adjuvants.
Vaccine 1989;7(5):421-4.
1989: P K Bentley; Stanley S Davis; O L Johnson; Kenneth C Lowe; C Washington
Purification of pluronic F-68 for perfluorochemical emulsification.
The Journal of pharmacy and pharmacology 1989;41(9):661-3.
1989: S G Woolfrey; K J Palin; Stanley S Davis
The effect of Miglycol 812 oil on the oral absorption of propranolol in the rat.
The Journal of pharmacy and pharmacology 1989;41(8):579-81.
1989: D T O'Hagan; K J Palin; Stanley S Davis
Poly(butyl-2-cyanoacrylate) particles as adjuvants for oral immunization.
Vaccine 1989;7(3):213-6.
1989: Colin D Melia; Stanley S Davis
Review article: mechanisms of drug release from tablets and capsules. I: Disintegration.
Alimentary pharmacology & therapeutics 1989;3(3):223-32.
1989: F Koosha; R H Muller; Stanley S Davis
Polyhydroxybutyrate as a drug carrier.
Critical reviews in therapeutic drug carrier systems 1989;6(2):117-30.
1988: Stanley S Davis; N Washington; G D Parr; A H Short; V A John; P Lloyd; S M Walker
Relationship between the rate of appearance of oxprenolol in the systemic circulation and the location of an oxprenolol Oros 16/260 drug delivery system within the gastrointestinal tract as determined by scintigraphy.
British journal of clinical pharmacology 1988;26(4):435-43.
1988: D Forster; C Washington; Stanley S Davis
Toxicity of solubilized and colloidal amphotericin B formulations to human erythrocytes.
The Journal of pharmacy and pharmacology 1988;40(5):325-8.
1988: N F Farraj; Stanley S Davis; G D Parr; H N Stevens
The stability and solubility of progabide and its related metabolic derivatives.
Pharmaceutical research 1988;5(4):226-31.
1988: Stanley S Davis; F Norring-Christensen; R Khosla; L C Feely
Gastric emptying of large single unit dosage forms.
The Journal of pharmacy and pharmacology 1988;40(3):205-7.
1988: Stanley S Davis; Lisbeth Illum
Polymeric microspheres as drug carriers.
Biomaterials 1988;9(1):111-5.
1988: D T O'Hagan; K J Palin; Stanley S Davis
Intestinal absorption of proteins and macromolecules and the immunological response.
Critical reviews in therapeutic drug carrier systems 1988;4(3):197-220.
1988: A D Bollands; Kenneth C Lowe; S K Sharma; Stanley S Davis
Biocompatibility studies with a novel perfluorochemical emulsion.
Biomaterials, artificial cells, and artificial organs 1988;16(1-3):451-3.
1988: S K Sharma; Kenneth C Lowe; Stanley S Davis
Novel compositions of emulsified perfluorochemicals for biological uses.
Biomaterials, artificial cells, and artificial organs 1988;16(1-3):447-50.
1987: A D Bollands; Kenneth C Lowe; S K Sharma; Stanley S Davis
Lymphoid tissue responses to a novel perfluorochemical emulsion in rats.
The Journal of pharmacy and pharmacology 1987;39(12):1021-4.
1987: J H Ratcliffe; I M Hunneyball; Clive G Wilson; A Smith; Stanley S Davis
Albumin microspheres for intra-articular drug delivery: investigation of their retention in normal and arthritic knee joints of rabbits.
The Journal of pharmacy and pharmacology 1987;39(4):290-5.
1987: N F Farraj; Stanley S Davis; G D Parr; H N Stevens
A reversed-phase high-performance liquid chromatography assay procedure for progabide and its related metabolic derivatives.
Pharmaceutical research 1987;4(1):28-32.
1987: S K Sharma; A D Bollands; Stanley S Davis; Kenneth C Lowe
Emulsified perfluorochemicals as physiological oxygen-transport fluids: assessment of a novel formulation.
Advances in experimental medicine and biology 1987;215():97-108.
1987: Stanley S Davis; C Washington; P West; Lisbeth Illum; G Liversidge; L Sternson; R Kirsh
Lipid emulsions as drug delivery systems.
Annals of the New York Academy of Sciences 1987;507():75-88.
1986: Lisbeth Illum; N W Thomas; Stanley S Davis
Effect of a selected suppression of the reticuloendothelial system on the distribution of model carrier particles.
Journal of pharmaceutical sciences 1986;75(1):16-22.
1985: Stanley S Davis; I M Hunneyball; L Illum; J H Ratcliffe; A Smith; Clive G Wilson
Recent advances in the use of microspheres for targeted therapy.
Drugs under experimental and clinical research 1985;11(9):633-40.
1984: J H Ratcliffe; I M Hunneyball; A Smith; Clive G Wilson; Stanley S Davis
Preparation and evaluation of biodegradable polymeric systems for the intra-articular delivery of drugs.
The Journal of pharmacy and pharmacology 1984;36(7):431-6.